Active, not recruitingPhase 4NCT05044611
AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
Studying Arginine vasopressin resistance
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- DECHANET Aline, MrsAssistance Publique - Hôpitaux de Paris (AP-HP)
- Intervention
- Anhydrous Amiloride Hydrochloride(drug)
- Enrollment
- 148 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2023 – 2026
Study locations (2)
- Néphrologie, Hôpital Henri-Mondor, Créteil, France
- Physiologie Explorations fonctionnelles multidisciplinaires, Hôpital Bichat, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05044611 on ClinicalTrials.gov